By
CDC advisors somewhat reluctantly voted in support of new bivalent versions of COVID-19 vaccines despite a lack of clinical trial data, citing the example of annual flu-shot revisions.
September 2, 2022 at 04:49AM
via WebMD Health read more...
CDC advisors somewhat reluctantly voted in support of new bivalent versions of COVID-19 vaccines despite a lack of clinical trial data, citing the example of annual flu-shot revisions.
0 Comments